Cargando…
CRKL oncogene is downregulated by p53 through miR-200s
Tumor suppressive miRNAs that target oncogenes are frequently downregulated in cancers, and this downregulation leads to oncogene pathway activation. Thus, tumor suppressive miRNAs and their target oncogenes have been proposed as useful targets in cancer treatment. miR-200 family downregulation has...
Autores principales: | Tamura, Miyuki, Sasaki, Yasushi, Kobashi, Kenta, Takeda, Kousuke, Nakagaki, Takafumi, Idogawa, Masashi, Tokino, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556393/ https://www.ncbi.nlm.nih.gov/pubmed/26079153 http://dx.doi.org/10.1111/cas.12713 |
Ejemplares similares
-
Identification and characterization of the intercellular adhesion molecule-2 gene as a novel p53 target
por: Sasaki, Yasushi, et al.
Publicado: (2016) -
Identification and characterization of a metastatic suppressor BRMS1L as a target gene of p53
por: Koyama, Ryota, et al.
Publicado: (2017) -
Profiling cancer-related gene mutations in oral squamous cell carcinoma from Japanese patients by targeted amplicon sequencing
por: Nakagaki, Takafumi, et al.
Publicado: (2017) -
Fledglings in p53 signaling network
por: Tokino, Takashi, et al.
Publicado: (2017) -
Prognostic Effect of Long Noncoding RNA NEAT1 Expression Depends on p53 Mutation Status in Cancer
por: Idogawa, Masashi, et al.
Publicado: (2019)